Valitor's Unattributed Round

Valitor raised a round of funding on September 21, 2018.

Valitor is a developer of methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. Its technology platform can be broad…

Articles about Valitor's Unattributed Round: